Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a Chinese biopharmaceutical company, has announced the signing of a licensing and supply agreement with Thailand-based Innobic. Under the terms of the deal, Innobic will support the registration and commercialization of Mabwell’s products in Thailand, a member country of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).
Innobic, a life sciences unit of the Petroleum Authority of Thailand, is focused on pharmaceuticals, medical technology, and nutrition businesses in Southeast Asia.- Flcube.com
